MergerLinks Header Logo

Request Deal Involvement

AbbVie completed the acquisition of ImmunoGen for $10.1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

JP Morgan

financial advisors

JP Morgan

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Morgan Stanley

financial advisors

Morgan Stanley

Cravath Swaine & Moore

legal advisors to financial advisors

Cravath Swaine & Moore

Ropes & Gray

legal advisors

Ropes & Gray

Goldman Sachs

financial advisors

Goldman Sachs

Lazard

financial advisors

Lazard

or

Principals

ABBVIE INC

bidder

ABBVIE INC

IMMUNOGEN

target

IMMUNOGEN

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - AbbVie completed the acquisition of ImmunoGen for $10.1bn.